Cez

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cez

The medicine Cez is defined by its active chemical substance, Cetirizine Hydrochloride, and its classification as a Second-Generation Antihistamine. It is generally positioned for the management of common allergy symptoms.

Property Description
Active ingredient Cetirizine Hydrochloride
Form Tablet, Syrup, Oral Solution (for oral administration)
Pharmacological class Antihistamine (Second-Generation)
Common purpose General anti-allergic relief
Origin Synthetic (Metabolite of Hydroxyzine)

What Type of Medicine is Cez and What is its Active Ingredient?

Cez is a pharmaceutical preparation whose core identity is the active ingredient, Cetirizine Hydrochloride. It belongs to the high-level pharmacological class of antihistamines, specifically categorized as a Second-Generation Antihistamine (SGAH). The chemical composition identifies Cetirizine as a synthetic compound, derived as a metabolite of Hydroxyzine and classified as a Phenylmethyl Piperazinyl Derivative. This class is recognized for its improved selective action compared to older antihistamines. As a single-ingredient product, its effect is attributable solely to Cetirizine Hydrochloride, which is commonly available as an Over-The-Counter (OTC) medication, making it easily accessible for general use.

Forms of Administration and General Anti-Allergic Purpose

The general purpose of Cez is to function as an anti-allergic agent. Its therapeutic effect stems from its action as a selective H1 receptor antagonist, which serves to block histamine. Blocking histamine is essential because this chemical messenger is responsible for initiating many allergic symptoms, such as the runny nose and watery eyes associated with hay fever. This means the medicine is specifically designed to interfere with the chemical pathway that triggers allergic discomfort. The medicine is designed for oral administration and is available in various dosage forms, including the film-coated tablet, chewable tablet, syrup, and oral solution.

What side effects are possible with Cez?

Official Safety Profile and Adverse Reactions

The safety profile of Cez (Cetirizine Hydrochloride) is formally categorized in regulatory documents based on the likelihood and nature of potential adverse reactions, ensuring clear communication of risk according to standard classification systems.

Frequency-Classified Adverse Reactions

Adverse effects are grouped by their official frequency of occurrence:

  • Common (1/100 to <1/10): Reactions frequently documented in regulatory labeling include somnolence (drowsiness), headache, fatigue, and dry mouth.
  • Uncommon (1/1,000 to <1/100): Effects such as agitation, pruritus (itching), rash, and diarrhea are listed.
  • Rare (1/10,000 to <1/1,000): This tier includes hypersensitivity reactions, tachycardia (increased heart rate), and abnormal liver function.
  • Very Rare (<1/10,000): These include severe events like anaphylactic shock (a severe allergic reaction), angioedema (severe swelling), and thrombocytopenia (low platelet count).

Regulatory Safety Considerations

The official labeling defines specific safety constraints for certain populations and conditions:

  • Severe Renal Impairment: The medicine is formally contraindicated in individuals with severe renal failure (creatinine clearance less than 10 ml/min). Dosage adjustments are required for patients with less severe forms of renal impairment.
  • Older Adults (Geriatrics): Caution is specified for this population due to the higher probability of decreased renal function, which may necessitate dosage modification.
  • Time-Related Patterns: Official documents note that side effects such as somnolence are typically dose-related and more common at the initiation of therapy. Cases of pruritus and urticaria have also been reported after discontinuation of the medicine.

This structured approach ensures the comprehensive disclosure of the drug's safety characteristics, from common, expected reactions to rare, serious adverse events.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents detail specific manifestations and mandatory actions required in the event of an overdose of Cez (Cetirizine Hydrochloride).

Documented Overdose Presentations

Overdose presentations primarily involve Central Nervous System (CNS) effects, including somnolence, sedation, fatigue, confusion, dizziness, and tremor. Symptoms that may suggest an anticholinergic effect, such as mydriasis (dilated pupils) and urinary retention, have also been documented. In adult cases, overdose is typically associated with intake of at least 5 times the recommended daily dose, while pediatric cases may exhibit initial excitement preceding drowsiness.

Severe Outcomes and Emergency Response

Severe manifestations documented in regulatory sources include tachycardia (rapid heartbeat), convulsions, deepening coma, and cardiorespiratory collapse. Due to the potential for these outcomes, seek immediate medical attention or contact a Poison Control Center right away if an overdose is suspected.

Immediately call emergency services if the person has collapsed, had a seizure, has trouble breathing, or can't be awakened.

Management and Antidote Status

Treatment for an overdose is strictly symptomatic and supportive. Regulatory labeling confirms that no known specific antidote for cetirizine is available. While gastric lavage may be considered following recent ingestion, the substance is not effectively removed by dialysis.

Therapeutic Uses of Cez

The core therapeutic utility of the medication Cez (Cetirizine Hydrochloride) is commonly used as a relevant agent for managing the symptomatic burden of multiple allergic conditions. It is considered relevant for the management of allergic rhinitis and chronic urticaria. The medicine is commonly applied in contexts where additional symptomatic support is needed across key domains, providing support that helps ease the overall symptom burden. It is used in conditions that present with disruptive symptom manifestations, including seasonal allergic rhinitis, perennial allergic rhinitis, and chronic urticaria.

The medication helps address symptom clusters involving frequent sneezing, runny nose, nasal itching, hives (weals), and itchy/watery eyes. Cez assists with maintaining functional stability by reducing the discomfort of symptoms that interfere with daily functioning, helping patients cope more steadily with difficult episodes. This support is vital in scenarios where symptoms become temporarily overwhelming.


Quick Fact Block

Quick Fact: Relief for Key Allergic Symptoms
Supports respiratory comfort by easing sneezing and runny nose; assists with easing challenging ocular symptoms; and contributes to improved comfort by reducing skin itching and hives.

Regulatory References

  1. NIH StatPearls overview on Cetirizine

Eligibility and Restrictions for Use

Cez, which contains the antihistamine cetirizine, is generally suitable for use by most adults and children aged 6 years and older for the treatment of various allergic symptoms, including seasonal and perennial allergic rhinitis and chronic idiopathic urticaria (hives). Some liquid formulations may be prescribed for children as young as 1 year old, but this should be under the guidance of a healthcare professional.


However, Cez is contraindicated and should not be used by individuals with a known allergy or severe hypersensitivity to cetirizine, any of its inactive ingredients, or to hydroxyzine (a related compound).


Caution and possible dose adjustment are necessary for other patient groups, as the drug's elimination is mainly through the kidneys. Individuals with moderate to severe kidney impairment or liver disease typically require a reduced dosage due to the slower clearance of the drug from the body. Because cetirizine can cause drowsiness, it should be used cautiously by those who perform tasks requiring mental alertness, and the consumption of alcohol or other central nervous system depressants should be avoided as this can intensify the sedative effect. Pregnant or breastfeeding women should consult a healthcare provider to weigh the potential benefits against the risks before use.

What should I know about interactions with other medicines?

The official drug interaction profile for Cez, as defined by authoritative government regulatory documents, focuses strictly on combinations that may alter the drug's exposure or compound its effects, thus requiring specific action. This information is derived from dedicated pharmacokinetic (PK) and pharmacodynamic (PD) studies.

Documented Interaction Categories

Interaction Type Description (as defined by regulatory sources)
Exposure-Altering (PK) Interactions affecting the systemic levels of Cez or a co-administered drug, primarily mediated by metabolic enzymes (e.g., CYP) or drug transporters (e.g., P-gp).
Pharmacodynamic Overlap (PD) Co-administration with other medicines that share a similar clinical effect, which may lead to additive results without a change in drug concentration.
Product-Specific Constraints Interactions with non-medicinal products, such as specific foods, alcohol, or herbal supplements (e.g., St. John's Wort), that demonstrably affect the drug's absorption or elimination.

Interaction-Related Requirements

Official labeling specifies restrictions for combinations that result in clinically significant changes to the drug's exposure (typically defined as a greater than two-fold change in AUC or C max). These restrictions include specific medicines or product classes whose co-administration is prohibited (Contraindicated Combinations). For other combinations, the official profile notes a need for heightened monitoring or conditional use. Furthermore, if a specific food or pH-altering agent (such as an antacid) impedes proper absorption, the regulatory documents mandate strict timing or separation requirements for co-administration. Population-specific notes detail if these interactions are more pronounced in patients with known organ impairment.

Mechanism of Action

Targeting the Histamine mathbfH1 Receptor

Cez acts as an inverse agonist/antagonist at the Histamine mathbfH1 Receptor, the primary molecular target located on various cell types, including endothelial cells and nerve endings. By binding to this receptor, the drug stabilizes its inactive state, thereby suppressing the ability of endogenous histamine to initiate cellular signaling. This action modifies the early molecular steps that would otherwise trigger downstream physiological activity.

Downstream Physiological Modulation

This molecular blockade exerts influence across two primary system-level domains. First, by targeting H1 receptors on the endothelium, Cez results in the stabilization of the microvascular system, which reduces the efflux of fluid and macromolecules into surrounding tissues. Second, the drug influences the peripheral nervous system by suppressing the H1 receptor-mediated transmission of afferent nerve signals, which alters the nerve signal response to mediator activity and influences the level of activity within peripheral sensory pathways.

Dosage and Administration Information

The administration of Cez (Cetirizine Hydrochloride) is governed by specific guidelines that define its route, dosage, and conditions for intake. The medicine is primarily designed for oral administration, available as a tablet (5 mg and 10 mg strengths) and an oral solution or syrup. For specialized, institutional use, an intravenous formulation (10 mg/mL injection) is administered as an IV push over a period of one to two minutes.

The standard dose for adults and adolescents aged 12 years and older is 10 mg taken once daily, though a 5 mg dose may be used for symptom management, with a maximum limit of 10 mg in a 24-hour period. A key instruction for proper administration is the flexibility regarding meals, as the medicine may be taken with or without food. Tablets must be swallowed whole using a glass of liquid.

Specific dose adjustments are required for certain patient populations. For patients with renal impairment, the dose must be individualized based on the degree of kidney function; for example, in cases of severe impairment, the interval between 5 mg doses may be extended to every two days. A lower starting dose of 5 mg once daily may also be indicated for older adults if their renal function is compromised. For pediatric patients aged 6 to 11 years, the standard dose is 5 mg or 10 mg once daily, administered either as a single dose or divided into two 5 mg doses. If a dose is missed, it should be taken when remembered, but double doses must be avoided by skipping the missed dose if the next scheduled time is near.

Recent Clinical Evidence

Research evidence / Overview of studies for Cez

The evidence available for Cez (Cetirizine Hydrochloride) comes primarily from formal clinical evaluations, including large-scale Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. This body of research has been used in studies exploring the medicine’s effects on key allergic conditions, focusing on how symptoms are measured in group settings.


Evidence for use in Allergic Rhinitis (Seasonal and Perennial)

Research concerning Cez was studied for allergic rhinitis, including seasonal and year-round symptoms, relying heavily on RCTs. Studies focused on key outcomes related to physical discomfort, tracking nasal and ocular symptoms. Measurements used were Total Symptom Scores (TSS) and Quality of Life (QOL) questionnaires, which evaluated outcomes reflecting daily functioning. Research highlights changes measured during the study period, and data show patterns related to these scores. The core research was conducted over short-term follow-up durations.


Evidence for use in Chronic Urticaria (Hives)

Chronic Urticaria was evaluated in settings involving chronic hives and skin itching. The research also includes Randomized Controlled Trials and specialized open-label studies. Research examined specific markers, such as the severity scores for weals (hives) and pruritus (itching), using tools like the Urticaria Activity Score (UAS). Findings indicate patterns related to how these skin symptoms evolved in the observed populations.


Evidence in Special Populations

Research has explored the use of Cez in various age groups. Pediatric populations were studied, with controlled data available for infants and children as young as 6 months. However, findings show evidence quality varies for certain secondary outcomes, such as QOL metrics. Furthermore, data for certain groups remain insufficient, particularly for specific outcomes in older adults (age 65 and above).


Long-Term Evidence and Structural Limitations

The clinical evidence primarily involves short-term or intermediate-duration studies, typically covering up to 12 weeks. Long-term effects are not fully established. The body of research describes certain limitations, including modest sample sizes and limited follow-up durations in research exploring symptoms that are refractory (unresponsive) to standard dosage. Comparative evidence is lacking in some areas, and the results apply only to the specific populations studied.

Key Studies & References

  1. Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis
  2. The international EAACI/ GA²LEN/ EuroGuiDerm/ APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Frequently Asked Questions (FAQ)

Common questions about Cez (FAQ)

Q: How quickly should I expect Cez to start working?

A: Official product information indicates that the medicine is rapidly absorbed after being taken orally. Peak levels of the drug in the body are typically reached within 30 to 60 minutes. The rapid absorption pattern is consistent with the onset of action often reported by patients.

Q: Does Cez cure the condition, or just manage the symptoms?

A: Regulatory documents state that Cez is indicated for the symptomatic treatment of allergic conditions. This means its role is to relieve or manage symptoms rather than provide a permanent cure. It works by blocking histamine, a chemical responsible for triggering many allergy symptoms.

Q: Is it normal to feel a bit tired when first starting Cez?

A: Yes, official safety information lists drowsiness (somnolence) and fatigue as common adverse reactions. Furthermore, regulatory sources note that the somnolence is more common when treatment is initiated.

Q: How long does the effect of a single dose of Cez typically last?

A: Cez is indicated for once-daily dosing, with its effects often lasting 24 hours. This duration is supported by the drug’s pharmacokinetic data, which shows its half-life—the time it takes for half the drug to be eliminated from the body—is typically around 7 to 11 hours in healthy adults.

Q: Can Cez affect my ability to drive or operate heavy machinery?

A: Regulatory warnings indicate that Cez can cause drowsiness, which could affect your ability to drive or use machinery. Official labeling advises caution when performing tasks requiring mental alertness, such as driving or operating heavy machinery.

Q: How often do people report serious side effects with Cez?

A: Serious adverse reactions, such as anaphylactic shock (a severe allergic reaction), are categorized in the official labeling as Very Rare. This classification means these serious events are estimated to occur in less than 1 out of every 10,000 patients treated.

Q: Can I stop taking Cez if I start feeling better?

A: Official safety documents report cases of severe itching (pruritus) and hives (urticaria) occurring after patients discontinued the medicine. If post-discontinuation symptoms occur, it may indicate a need to consult with a healthcare professional.

Q: Are there any long-term side effects associated with taking Cez for many years?

A: Regulatory documents report cases of severe itching or hives occurring after patients stopped taking the medication following long-term, continuous daily use. Additionally, regulatory documents mention that good oral hygiene is suggested, especially if dry mouth is experienced during prolonged therapy.

Q: Is it possible to develop a tolerance to Cez over time?

A: Official clinical studies exploring the drug’s effects over time have reported that no significant tolerance, meaning a reduction in the drug's effectiveness, was found in patient populations that received prolonged administration.

Q: Why is regular monitoring sometimes recommended when taking Cez?

A: Monitoring, which may include assessing kidney function, is required for certain patient groups. Regulatory documents emphasize the need to individualize the dose for people with kidney impairment, which may necessitate medical observation.

Q: What should I do if I accidentally miss a dose of Cez?

A: Official directions state that if you miss a dose, you should take it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose. Regulatory information advises against taking a double dose to make up for the missed one.

Q: Is it true that Cez can cause weight changes?

A: Increased appetite is listed as an adverse reaction in some regulatory documents, though the frequency is 'Not known.' An increased appetite is a factor that could potentially lead to weight changes.

Q: Does Cez interact with common vitamins or herbal supplements?

A: Official prescribing information provides specific data regarding interactions with substances like St. John's Wort and theophylline. However, the regulatory documents do not provide explicit details about interactions with general vitamins or many other herbal supplements.

Q: What are the signs of an allergic reaction to Cez?

A: Official warnings state that you should stop taking the medicine and seek emergency help immediately if an allergic reaction occurs. Very rare, severe reactions documented include anaphylactic shock and angioedema, which involves severe swelling of the face, tongue, or throat.

Q: Is there a generic version of Cez available?

A: The active ingredient in Cez, Cetirizine Hydrochloride, is widely available as a commonly used over-the-counter (OTC) medication. This means the drug component is easily accessible for general use.

Q: Can Cez be crushed or split if someone has trouble swallowing pills?

A: Standard tablets are instructed to be swallowed whole with liquid. Other formulations are available for patients who may have difficulty swallowing, but the standard tablet should not be altered. Consult the specific instructions for the form of the medicine you are using.

Q: Why do different patients sometimes take different forms or strengths of Cez?

A: Official labeling dictates that different strengths and forms, such as oral solution or syrup, are necessary to allow for dose individualization. This is particularly important for patients with specific needs, such as children in different age groups or adults with impaired kidney function.

Q: What happens if I take too much Cez?

A: In the case of a suspected overdose, it is essential to seek emergency medical attention. Regulatory documents report that symptoms of an overdose are typically associated with effects on the central nervous system, such as feeling confused, extremely tired, or unusually restless.

Q: Does Cez have any known effect on mood or anxiety levels?

A: Adverse reaction profiles in regulatory sources list a number of psychiatric disorders. These include uncommon effects like agitation, rare effects such as confusion or depression, and reports of insomnia or suicidal ideation with 'Not known' frequency.

Q: Are there any lab tests required before or during treatment with Cez?

A: Official information states that the medicine may need to be discontinued for a specific period before allergy skin testing, as it can inhibit the test results. Consult the label for specific details regarding pre-testing procedures.

Q: How long after stopping Cez will it be completely out of my system?

A: The official half-life of the drug in healthy adults is typically between 6.7 and 10.7 hours. Since it generally takes several half-lives for a drug to be completely cleared, this provides an indication of the time required for full elimination from the body.

Q: Is it normal for the side effects of Cez to go away after a few weeks?

A: Regulatory labeling notes that drowsiness (somnolence) is more common when therapy is initiated. This information implies that this specific side effect may decrease or resolve as the body adjusts to the medicine over the first few weeks of treatment.

How should Cez be stored and disposed of?

Storage and Disposal Requirements for Cetirizine Hydrochloride

The medicine must be stored at Controlled Room Temperature, specifically between 20°C to 25°C (68°F to 77°F). Liquid formulations, such as the oral solution, must be Protected from light, while the orally disintegrating tablets must be stored while avoiding high humidity. All forms of the medication must be securely stored out of the sight and reach of children.

Storage Condition Requirement
Temperature Range 20 C to 25 C
Light Protection Mandatory for Oral Solution
Child Safety Keep out of reach of children

Disposal must adhere to official regulatory protocols. The preferred method for discarding unused or expired product is an authorized drug take-back program. If a take-back option is unavailable, the medication should be mixed with an undesirable substance, such as dirt or used coffee grounds, placed in a sealed container, and then discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cez found in:

A-Z Index: